Previous Close | 18.72 |
1-Year Change | -37.37% |
6-Months Change | 0% |
3-Months Change | -9.65% |
Moving Avg (50d) | 19.185 |
Moving Avg (200d) | 21.293 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 2.78B |
Beta (3-Years) | 1.45 |
Revenue Growth (ttm) | -14.61% |
Net Profit Margin (ttm) | -5.13% |
Return On Assets (ttm) | -3.88% |
EPS (ttm) | -1.99 |
PE Ratio (ttm) | -9.41 |
Dividend Yield | 5.34% |
Asset Description: | The Chemours Company |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2025-01-28 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
19.094 | 19.656 | 20.03 | 20.592 | 21.528 | 22.464 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.